Russell Green, director product growth for Drug Discovery and Synthetic Biology, Automata, describes three reasons why automation should become an integral part of the vaccine development process.
Adnan Khan, manager of pharma industries at Beckhoff UK, discusses the challenges of pharmaceutical production lines and how next-generation motion can help.
Mark Hilhorst, CEO of Jekson Vision, provides insight into the stringent quality checks needed that are crucial to improve patient safety in the pharma market, and how automation solutions can help with this, while meeting growing market demand.
Allison Hoffman, global product manager, Cell Therapy Technologies, Terumo BCT, discusses how automation is leading the way to optimising autologous manufacturing in the C> sector.
Mark Yeeles, VP Industrial Automation, Schneider Electric, examines five important areas pharmaceutical facilities need to be aware of to transform their operations and improve production.
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
Jon Brewin, business development manager for AutoStore, discusses increasing demands on pharmaceutical supply chains and how automation can improve lead times.
David Leitham, senior vice president and general manager at software company AspenTech looks at why process analytical technology (PAT) is essential for the journey to Pharma 4.0.
EPM speaks to Nigel Skinner, Marketing Director at Andrew Alliance about how automation is being used throughout the pharma industry and how it is helping bring new drugs to market faster.
Richard Porter, pharmaceutical director at AspenTech looks at how automated technologies are helping pharma companies transform their manufacturing processes.
